These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28252221)

  • 1. Bone Marrow-Derived Mesenchymal Stem Cells-Mediated Protection Against Organ Dysfunction in Disseminated Intravascular Coagulation Is Associated With Peripheral Immune Responses.
    Wang B; Wu S; Wang T; Ma Z; Liu K
    J Cell Biochem; 2017 Oct; 118(10):3184-3192. PubMed ID: 28252221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMSCs pre-treatment ameliorates inflammation-related tissue destruction in LPS-induced rat DIC model.
    Wang B; Wu S; Ma Z; Wang T; Yang C
    Cell Death Dis; 2018 Oct; 9(10):1024. PubMed ID: 30282969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model.
    Wang B; Wu SM; Wang T; Liu K; Zhang G; Zhang XQ; Yu JH; Liu CZ; Fang CC
    Chin Med J (Engl); 2012 May; 125(10):1753-9. PubMed ID: 22800895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S
    Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of immuno-tolerance mechanism of the third-party bone marrow-derived mesenchymal stem cells in allogenic transplantation].
    Qi BD; Meng BX; Yang Y; Liu B; Li CC; Xia W; Guo SZ; Zhang C
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):207-12. PubMed ID: 21838003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of HMGB1-RAGE/TLRs-NF-κB signaling pathway on bone mesenchymal stem cells transplantation therapy for lipopolysaccaride-induced coagulation disorder rats].
    Xiu G; Xiong W; Yin Y; Chen X; Liu P; Sun J; Ling B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):830-835. PubMed ID: 30309407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
    Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels.
    Asakura H; Asamura R; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Yoshida T; Miyamoto K; Nakao S
    Thromb Haemost; 2005 Apr; 93(4):724-8. PubMed ID: 15841319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Marrow Mesenchymal Stem Cells Suppress Acute Lung Injury Induced by Lipopolysaccharide Through Inhibiting the TLR2, 4/NF-κB Pathway in Rats with Multiple Trauma.
    Li D; Pan X; Zhao J; Chi C; Wu G; Wang Y; Liao S; Wang C; Ma J; Pan J
    Shock; 2016 Jun; 45(6):641-6. PubMed ID: 26717106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
    Asakura H; Sano Y; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
    Intensive Care Med; 2004 Oct; 30(10):1950-5. PubMed ID: 15480547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy.
    Liao L; Shi B; Chang H; Su X; Zhang L; Bi C; Shuai Y; Du X; Deng Z; Jin Y
    Theranostics; 2017; 7(1):106-116. PubMed ID: 28042320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of bone marrow mesenchymal stem cells with CTLA4Ig and CD40LIg gene modification in rejection reaction after liver transplantation].
    Sun C; Zhang J; Yin DL; Li K; Wang Q; Xie YH; Li W
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):54-59. PubMed ID: 29804363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of human hepatocyte growth factor gene-modified bone marrow mesenchymal stem cells on immunological rejection after allograft liver transplantation in rats].
    Zhu J; Chen Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jul; 25(7):871-6. PubMed ID: 21818958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.
    Asakura H; Ichino T; Yoshida T; Suga Y; Ontachi Y; Mizutani T; Kato M; Ito T; Yamazaki M; Aoshima K; Morishita E; Saito M; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):233-9. PubMed ID: 11943937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA protects rabbits against LPS-induced disseminated intravascular coagulation (DIC).
    Wu LC; Lin X; Sun H
    Acta Pharmacol Sin; 2012 Oct; 33(10):1254-9. PubMed ID: 22983394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models.
    Asakura H; Aoshima K; Ichino T; Suga Y; Saito M; Morishita E; Yamazaki M; Ontachi Y; Mizutani T; Kato M; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):301-6. PubMed ID: 11460014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H; Sano Y; Omote M; Yoshida T; Ontachi Y; Mizutani T; Kaneda M; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
    Int J Hematol; 2004 May; 79(4):394-9. PubMed ID: 15218973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reproduction of a rat model of disseminated intravascular coagulation accompanied by multiple organ injuries].
    Qiao YJ; Zhu JM; Zhang Y; Yuan HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):41-3. PubMed ID: 17207364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvianolic acid A alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting complement activation.
    Zhang QY; Guo J; Xu L; Wei Y; Zhou ST; Lu QY; Guo L; Sun QY
    BMC Complement Med Ther; 2022 Sep; 22(1):245. PubMed ID: 36127691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of exogenous bone marrow‑derived mesenchymal stem cell transplantation on silicosis via paracrine mechanisms in rats.
    Zhao MM; Cui JZ; Cui Y; Li R; Tian YX; Song SX; Zhang J; Gao JL
    Mol Med Rep; 2013 Sep; 8(3):741-6. PubMed ID: 23842733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.